2020 ASCO Virtual Direct™ Highlights
Skin
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Highlights on Metastatic Melanoma: What Is the Optimal Dosing of Ipilimumab + Nivolumab?
FEATURING
Gary Doolittle
- 182 views
- July 22, 2020
- 1
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Follow up on Adjuvant Therapy in High-risk Melanoma: Does Pembro Provide Sustained RFS Benefit in Resected Stage III Melanoma? Is There a Long-term Survival Benefit With Dabrafenib + Trametinib in BRAF+ Disease?
FEATURING
Gary Doolittle
- 104 views
- July 22, 2020